Novugen

Novugen is a vertically integrated pharmaceutical company based in Malaysia that specializes in the development and manufacturing of complex generics and oncology products. The company operates a state-of-the-art, GMP-certified high-containment facility, which is the first of its kind in Southeast Asia, designed to produce potent oral solids and injectables. Novugen focuses on hard-to-source medicines, aiming to improve global accessibility and affordability in therapeutic areas such as oncology, cardiovascular, and the central nervous system. With a strong R&D presence in both Malaysia and the United States, the company manages the entire product lifecycle from API sourcing to finished dosage forms. Their strategic goal is to provide high-quality, cost-effective alternatives to expensive specialty medicines for markets in North America, Europe, and the Middle East.